FDA says studies confirm "new" heparin is less potent
This article was originally published in Scrip
Executive Summary
The US FDA says that laboratory tests confirm that "new" heparin, or heparin manufactured under a revised US Pharmacopeia (USP) monograph, has approximately 10% less anticoagulant activity compared to "old" heparin.